Search Weight Loss Topics:




Mar 30

Canagliflozin/Phentermine Results in Superior Weight Loss in Obesity Without Diabetes – Endocrinology Advisor

Canagliflozin/Phentermine Results in Superior Weight Loss in Obesity Without Diabetes
Endocrinology Advisor
HealthDay News For obese or overweight individuals without type 2 diabetes, coadministration of canagliflozin (CANA) and phentermine (PHEN) is associated with considerable weight loss and is well tolerated, according to a study published online in ...

View post:
Canagliflozin/Phentermine Results in Superior Weight Loss in Obesity Without Diabetes - Endocrinology Advisor

Related Posts

    Your Full Name

    Your Email

    Your Phone Number

    Select your age (30+ only)

    Select Your US State

    Program Choice

    Confirm over 30 years old

    Yes

    Confirm that you resident in USA

    Yes

    This is a Serious Inquiry

    Yes

    Message:



    matomo tracker